These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 22267018

  • 1. What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples.
    Ware NC, Wyatt MA, Haberer JE, Baeten JM, Kintu A, Psaros C, Safren S, Tumwesigye E, Celum CL, Bangsberg DR.
    J Acquir Immune Defic Syndr; 2012 Apr 15; 59(5):463-8. PubMed ID: 22267018
    [Abstract] [Full Text] [Related]

  • 2. Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa.
    Haberer JE, Baeten JM, Campbell J, Wangisi J, Katabira E, Ronald A, Tumwesigye E, Psaros C, Safren SA, Ware NC, Thomas KK, Donnell D, Krows M, Kidoguchi L, Celum C, Bangsberg DR.
    PLoS Med; 2013 Apr 15; 10(9):e1001511. PubMed ID: 24058300
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention.
    Mujugira A, Baeten JM, Donnell D, Ndase P, Mugo NR, Barnes L, Campbell JD, Wangisi J, Tappero JW, Bukusi E, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kidoguchi L, Panteleeff D, Krows M, Shah H, Revall J, Morrison S, Ondrejcek L, Ingram C, Coombs RW, Lingappa JR, Celum C, Partners PrEP Study Team.
    PLoS One; 2011 Apr 15; 6(10):e25828. PubMed ID: 21998703
    [Abstract] [Full Text] [Related]

  • 4. Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges.
    McMahon JM, Myers JE, Kurth AE, Cohen SE, Mannheimer SB, Simmons J, Pouget ER, Trabold N, Haberer JE.
    AIDS Patient Care STDS; 2014 Sep 15; 28(9):462-74. PubMed ID: 25045996
    [Abstract] [Full Text] [Related]

  • 5. I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation.
    Ngure K, Heffron R, Curran K, Vusha S, Ngutu M, Mugo N, Celum C, Baeten JM.
    AIDS Patient Care STDS; 2016 Feb 15; 30(2):78-83. PubMed ID: 26836236
    [Abstract] [Full Text] [Related]

  • 6. Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial.
    Kibengo FM, Ruzagira E, Katende D, Bwanika AN, Bahemuka U, Haberer JE, Bangsberg DR, Barin B, Rooney JF, Mark D, Chetty P, Fast P, Kamali A, Priddy FH.
    PLoS One; 2013 Feb 15; 8(9):e74314. PubMed ID: 24086333
    [Abstract] [Full Text] [Related]

  • 7. Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples.
    Nakku-Joloba E, Pisarski EE, Wyatt MA, Muwonge TR, Asiimwe S, Celum CL, Baeten JM, Katabira ET, Ware NC.
    J Int AIDS Soc; 2019 Jan 15; 22(1):e25225. PubMed ID: 30657642
    [Abstract] [Full Text] [Related]

  • 8. Lay Social Resources for Support of Adherence to Antiretroviral Prophylaxis for HIV Prevention Among Serodiscordant Couples in sub-Saharan Africa: A Qualitative Study.
    Ware NC, Pisarski EE, Haberer JE, Wyatt MA, Tumwesigye E, Baeten JM, Celum CL, Bangsberg DR.
    AIDS Behav; 2015 May 15; 19(5):811-20. PubMed ID: 25267114
    [Abstract] [Full Text] [Related]

  • 9. Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
    Bazzi AR, Leech AA, Biancarelli DL, Sullivan M, Drainoni ML.
    AIDS Patient Care STDS; 2017 Aug 15; 31(8):348-355. PubMed ID: 28719229
    [Abstract] [Full Text] [Related]

  • 10. Sexual Relationships Outside Primary Partnerships and Abstinence Are Associated With Lower Adherence and Adherence Gaps: Data From the Partners PrEP Ancillary Adherence Study.
    Kintu A, Hankinson SE, Balasubramanian R, Ertel K, Tumwesigye E, Bangsberg DR, Haberer JE, Partners Ancillary Adherence Study Team.
    J Acquir Immune Defic Syndr; 2015 May 01; 69(1):36-43. PubMed ID: 25942457
    [Abstract] [Full Text] [Related]

  • 11. HIV preexposure prophylaxis: new data and potential use.
    Celum CL.
    Top Antivir Med; 2011 Dec 01; 19(5):181-5. PubMed ID: 22298887
    [Abstract] [Full Text] [Related]

  • 12. PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.
    Gilbert HN, Wyatt MA, Pisarski EE, Muwonge TR, Heffron R, Katabira ET, Celum CL, Baeten JM, Haberer JE, Ware NC.
    J Acquir Immune Defic Syndr; 2019 Nov 01; 82(3):265-274. PubMed ID: 31609925
    [Abstract] [Full Text] [Related]

  • 13. Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial.
    Mugwanya KK, Wyatt C, Celum C, Donnell D, Mugo NR, Tappero J, Kiarie J, Ronald A, Baeten JM, Partners PrEP Study Team.
    JAMA Intern Med; 2015 Feb 01; 175(2):246-54. PubMed ID: 25531343
    [Abstract] [Full Text] [Related]

  • 14. Pre-exposure prophylaxis for conception (PrEP-C) as a risk reduction strategy in HIV-positive men and HIV-negative women in the UK.
    Whetham J, Taylor S, Charlwood L, Keith T, Howell R, McInnes C, Payne E, Home J, White D, Gilleece Y.
    AIDS Care; 2014 Feb 01; 26(3):332-6. PubMed ID: 23876052
    [Abstract] [Full Text] [Related]

  • 15. Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial.
    Celum C, Morrow RA, Donnell D, Hong T, Hendrix CW, Thomas KK, Fife KH, Nakku-Joloba E, Mujugira A, Baeten JM, Partners PrEP Study Team.
    Ann Intern Med; 2014 Jul 01; 161(1):11-9. PubMed ID: 24979446
    [Abstract] [Full Text] [Related]

  • 16. Gendered differences in the perceived risks and benefits of oral PrEP among HIV-serodiscordant couples in Kenya.
    Carroll JJ, Ngure K, Heffron R, Curran K, Mugo NR, Baeten JM.
    AIDS Care; 2016 Aug 01; 28(8):1000-6. PubMed ID: 26754017
    [Abstract] [Full Text] [Related]

  • 17. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE, Kidoguchi L, Heffron R, Mugo N, Bukusi E, Katabira E, Asiimwe S, Thomas KK, Celum C, Baeten JM.
    J Int AIDS Soc; 2017 Jul 25; 20(1):21842. PubMed ID: 28741331
    [Abstract] [Full Text] [Related]

  • 18. High medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral pre-exposure prophylaxis.
    Matthews LT, Heffron R, Mugo NR, Cohen CR, Hendrix CW, Celum C, Bangsberg DR, Baeten JM, Partners PrEP Study Team.
    J Acquir Immune Defic Syndr; 2014 Sep 01; 67(1):91-7. PubMed ID: 25118795
    [Abstract] [Full Text] [Related]

  • 19. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    Morton JF, Celum C, Njoroge J, Nakyanzi A, Wakhungu I, Tindimwebwa E, Ongachi S, Sedah E, Okwero E, Ngure K, Odoyo J, Bulya N, Haberer JE, Baeten JM, Heffron R, Partners Demonstration Project Team.
    J Acquir Immune Defic Syndr; 2017 Jan 01; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial.
    Murnane PM, Celum C, Mugo N, Campbell JD, Donnell D, Bukusi E, Mujugira A, Tappero J, Kahle EM, Thomas KK, Baeten JM, Partners PrEP Study Team.
    AIDS; 2013 Aug 24; 27(13):2155-60. PubMed ID: 24384592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.